ArticlePharmaceuticals (Basel, Switzerland)2025

Rosuvastatin Versus Atorvastatin for Cardiovascular Disease Risk in Patients with Type 2 Diabetes: A Korean Cohort Study.

Chaeyoon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.